19.02.2013 - Larry Bell has joined Leiden-based Prosensa Therapeutics as VP Global Regulatory Affairs.
He will be based in the US, said the Dutch specialist for RNA-modulating therapeutics. He brings in more than 18 years experience in running regulatory affairs and has worked with Merck, Bristol-Myers Squibb, Aventis and Amgen. Before setting up his own consultancy, in his most recent role he was Vice President and Global Head of Regulatory Affairs at GE Healthcare. He completed his MD at the University of Texas Medical Branch.http://www.european-biotechnology-news.com/people/bio-people/2013-01/larry-bell.html